At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Jun 23, 2026 at 21:13 ET
uniQure priced an underwritten public offering of 4,945,055 ordinary shares at $45.50 per share, expecting approximately $225 million in gross proceeds. The offering includes a 30-day underwriter option for up to 741,758 additional shares. This dilutive capital raise provides cash runway for gene therapy pipeline programs (Huntington's, epilepsy, Fabry) but dilutes existing shareholders by roughly 10% based on the base offering.
- Priced 4,945,055 ordinary shares at $45.50 per share for ~$225M gross proceeds
- Underwriters have 30-day option to purchase up to 741,758 additional shares
- Offering expected to close on or about June 25, 2026
- Joint bookrunners: Leerink Partners, Stifel, Guggenheim Securities, RBC Capital Markets
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access